Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Frederic Colombel

Showing results (161-170 of 462) with videos related to

Pageof 47
Sort By:
Alimentary Pharmacology & Therapeutics|June 6, 2019
Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel diseaseAdam Tepler, Neeraj Narula, Richard M Peek, et al.
The American Journal of Gastroenterology|September 29, 2021
A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn's DiseaseParambir S Dulai, Vipul Jairath, Neeraj Narula, et al.
Inflammatory Bowel Diseases|July 28, 2021
New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International RegistryRyan C Ungaro, Manasi Agrawal, Erica J Brenner, et al.
Gastroenterology|October 19, 2019
Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver DiseasesXavier Verhelst, Ana M Dias, Jean-Frederic Colombel, et al.
United European Gastroenterology Journal|August 21, 2025
Environmental and Inflammatory Factors Drive Perinuclear-Antineutrophil Cytoplasmic Antibodies (pANCA) in Ulcerative Colitis: A European Twin StudyDaniel Bergemalm, Karin Amcoff, Marie J Pierik, et al.
Journal of Crohn'S & Colitis|July 12, 2025
Scoring indices for assessing endoscopic disease activity in acute severe ulcerative colitis: A systematic reviewHadar Meringer, Maia Kayal, Vipul Jairath, et al.
Crohn'S & Colitis 360|February 5, 2026
Patients' attitudes to disease prevention in inflammatory bowel disease: a US-based surveyMary Harkins-Schwarz, Catarina Bravo, Manasi Agarawal, et al.
The American Journal of Gastroenterology|February 10, 2016
Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to SteroidsNeeraj Narula, John K Marshall, Jean-Frederic Colombel, et al.
Digestive Diseases and Sciences|June 28, 2021
Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel DiseaseRajen Parekh, Xian Zhang, Ryan C Ungaro, et al.
Clinical Colorectal Cancer|October 16, 2016
Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel DiseaseJordan Axelrad, Anuja Kriplani, Umut Ozbek, et al.
Pageof 47

Showing results (161-170 of 462) with videos related to

Sort By:
Pageof 47
Alimentary Pharmacology & Therapeutics|June 6, 2019
Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel diseaseAdam Tepler, Neeraj Narula, Richard M Peek, et al.
The American Journal of Gastroenterology|September 29, 2021
A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn's DiseaseParambir S Dulai, Vipul Jairath, Neeraj Narula, et al.
Inflammatory Bowel Diseases|July 28, 2021
New Gastrointestinal Symptoms Are Common in Inflammatory Bowel Disease Patients With COVID-19: Data From an International RegistryRyan C Ungaro, Manasi Agrawal, Erica J Brenner, et al.
Gastroenterology|October 19, 2019
Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver DiseasesXavier Verhelst, Ana M Dias, Jean-Frederic Colombel, et al.
United European Gastroenterology Journal|August 21, 2025
Environmental and Inflammatory Factors Drive Perinuclear-Antineutrophil Cytoplasmic Antibodies (pANCA) in Ulcerative Colitis: A European Twin StudyDaniel Bergemalm, Karin Amcoff, Marie J Pierik, et al.
Journal of Crohn'S & Colitis|July 12, 2025
Scoring indices for assessing endoscopic disease activity in acute severe ulcerative colitis: A systematic reviewHadar Meringer, Maia Kayal, Vipul Jairath, et al.
Crohn'S & Colitis 360|February 5, 2026
Patients' attitudes to disease prevention in inflammatory bowel disease: a US-based surveyMary Harkins-Schwarz, Catarina Bravo, Manasi Agarawal, et al.
The American Journal of Gastroenterology|February 10, 2016
Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to SteroidsNeeraj Narula, John K Marshall, Jean-Frederic Colombel, et al.
Digestive Diseases and Sciences|June 28, 2021
Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel DiseaseRajen Parekh, Xian Zhang, Ryan C Ungaro, et al.
Clinical Colorectal Cancer|October 16, 2016
Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel DiseaseJordan Axelrad, Anuja Kriplani, Umut Ozbek, et al.
Pageof 47